Keywords: Colombia, Pharma market, BMI, Intelectual property, Pricing, Reimbursement, Generic substitution

Colombian pharmaceutical market offers long-term rewards, says BMI

Article | 18 March 2011

Colombia has been ravaged by decades of civil conflict and the fighting has internally displaced nearly 3 million people over the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in